The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126128344 12612834 4 F 20160721 20160830 20160802 20160908 EXP JP-AMGEN-JPNSP2016099476 AMGEN 63.00 YR A F Y 0.00000 20160907 PH JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126128344 12612834 1 PS G-LASTA PEGFILGRASTIM 1 Subcutaneous 3.6 MG, SINGLE Y 125031 3.6 MG SOLUTION FOR INJECTION
126128344 12612834 2 SS PACLITAXEL. PACLITAXEL 1 Intravenous drip UNK 0 INJECTION
126128344 12612834 3 SS PACLITAXEL. PACLITAXEL 1 Intravenous drip 230 MG, UNK 0 230 MG INJECTION
126128344 12612834 4 SS PACLITAXEL. PACLITAXEL 1 Intravenous drip 200 MG, UNK 0 200 MG INJECTION
126128344 12612834 5 C DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Intravenous drip UNK 0 INJECTION
126128344 12612834 6 C CYCLOPHOSPHAMIDE MONOHYDRATE CYCLOPHOSPHAMIDE 1 Intravenous drip UNK 0 INJECTION
126128344 12612834 7 C TS-1 GIMERACILOTERACILTEGAFUR 1 Oral UNK 0
126128344 12612834 8 C TS-1 GIMERACILOTERACILTEGAFUR 1 Oral UNK 0
126128344 12612834 9 C LIPITOR ATORVASTATIN CALCIUM 1 Oral 5 MG, QD 0 5 MG TABLET QD
126128344 12612834 10 C AMLODIN AMLODIPINE BESYLATE 1 Oral 5 MG, QD 0 5 MG TABLET QD
126128344 12612834 11 C GRAN FILGRASTIM 1 Unknown UNK 0 INJECTION
126128344 12612834 12 C TAXOTERE DOCETAXEL 1 Intravenous drip UNK 0 INJECTION
126128344 12612834 13 C TAXOTERE DOCETAXEL 1 Intravenous drip UNK 0 INJECTION
126128344 12612834 14 C TAXOTERE DOCETAXEL 1 Intravenous drip UNK 0 INJECTION
126128344 12612834 15 C TAXOTERE DOCETAXEL 1 Intravenous drip UNK 0 INJECTION
126128344 12612834 16 C DEXART DEXAMETHASONE SODIUM PHOSPHATE 1 Intravenous drip 19.8 MG, UNK 0 19.8 MG INJECTION
126128344 12612834 17 C GASTER FAMOTIDINE 1 Intravenous (not otherwise specified) 20 MG, UNK 0 20 MG INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126128344 12612834 1 Colony stimulating factor prophylaxis
126128344 12612834 2 Breast cancer
126128344 12612834 5 Breast cancer
126128344 12612834 6 Breast cancer
126128344 12612834 7 Breast cancer

Outcome of event

Event ID CASEID OUTC COD
126128344 12612834 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126128344 12612834 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126128344 12612834 1 20160715 20160715 0
126128344 12612834 3 20160714 20160714 0
126128344 12612834 4 20160804 20160804 0
126128344 12612834 5 20140811 20140811 0
126128344 12612834 6 20140811 20140811 0
126128344 12612834 8 20151019 0
126128344 12612834 11 201408 201408 0
126128344 12612834 12 20141110 20150119 0
126128344 12612834 13 20150420 0
126128344 12612834 14 20150615 0
126128344 12612834 15 20150907 0
126128344 12612834 16 20160714 20160804 0
126128344 12612834 17 20160714 20160804 0